Story Details
| Last Updated | |
| Total Articles | 4 |
Main Topics
develops, produces, and markets drugs or pharmaceuticals licensed for use as medications
News on this topic
India's Glenmark Pharma unit, AbbVie sign exclusive licensing pact: India's Glenmark Pharmaceuticals said on Thursday its innovation arm, Ichnos Glenmark ...
reuters.com/business/healthcare-pharmaceuticals/indias-glenmark-pharma-unit-abbvie-sign-exclusive-licensing-pact-2025-07-10/
Similar to This
Previous
Ashish Dhawan just sold off two of his long time favourites – Time to be cautious?
financialexpress.com/market/stock-insights/ashish-dhawan-just-sold-off-two-of-his-long-time-favourites-time-to-be-cautious/4022024/
Dividend stocks: Glenmark Pharma only stock to trade ex-dividend this week: Dividend stocks this week, September 28: Glenmark Pharma trades ex-dividend on Oct 3; ...
financialexpress.com/market/dividend-stocks-glenmark-pharma-only-stock-to-trade-ex-dividend-this-week-3991843/
More pain ahead for Glenmark Pharma? 3 reasons why Nomura sees 25% downside after licencing deal for cancer drug
financialexpress.com/market/more-pain-ahead-for-glenmark-pharma-3-reasons-why-nomura-sees-25-downside-after-licencing-deal-for-cancer-drug-3988811/
Glenmark inks exclusive licensing pact with Hengrui for next-gen cancer drug; to make $18 m upfront payment
financialexpress.com/business/industry-glenmark-inks-exclusive-licensing-pact-with-hengruinbsp-for-next-gen-cancer-drug-to-make-18-m-upfront-payment-3988094/
The FDA Is Cracking Down on an Indian Drugmaker Investigated by ProPublica Last Year
propublica.org/article/fda-letter-glenmark-pharmaceuticals
Markets end the week muted: Nifty closes below 25,200, Nifty IT Index down 2%- 5 key highlights
financialexpress.com/market/markets-end-the-week-muted-nifty-closes-below-25200-nifty-it-index-down-2-5-key-highlights-3911041/
Near-term upside from deal with AbbVie may be priced in Glenmark's stock: Glenmark Pharma's exclusive licensing deal with AbbVie for ISB-2001 could be ...
business-standard.com/markets/news/near-term-upside-from-deal-with-abbvie-may-be-priced-in-glenmarks-stock-125071101179_1.html
Paid articlePaywall
AbbVie: New deal - | Indian pharmaceutical stock soars: AbbVie buys rights to Glenmark's cancer drug ISB 2001.
deraktionaer.de/artikel/pharma-biotech/abbvie-neuer-deal-indische-pharma-aktie-fliegt-20383072.html
India's Glenmark Pharma soars 10% to record high on AbbVie cancer treatment licensing deal
reuters.com/business/healthcare-pharmaceuticals/glenmark-pharma-jumps-units-cancer-licensing-deal-with-abbvie-2025-07-11/
Big news: AbbVie inks $700 million pact with Glenmark arm to develop and sell new cancer drug
financialexpress.com/business/industry-big-newsnbsp-abbvie-inks-700-million-pact-with-glenmark-arm-to-develop-and-sell-new-cancer-drug-3910634/
Next